Cerebrolysin Lyophilized Powder | 98%High purity Factory manufactured

Sale

Cerebrolysin Lyophilized Powder | 98%High purity Factory manufactured

(2 customer reviews)

Original price was: $10.00.Current price is: $8.00.

Cerebrolysin Lyophilized Powder is a standardized neurotrophic compound preparation derived from enzymatic hydrolysis of porcine brain proteins, enriched in low-molecular-weight neuroactive peptides and free amino acids. It is widely utilized in neuroscience, neurodegeneration, synaptic plasticity, and neuroprotection research models for its multimodal actions on neuronal survival, differentiation, and functional recovery.

EMI starting from $0.00/month - View Plans
Category: Tag:

Description

Product Description

Cerebrolysin is a complex neurotrophic formulation composed of biologically active low-molecular-weight peptides (<10 kDa) and free amino acids obtained through controlled enzymatic cleavage of brain-specific proteins. Unlike single-target neuroactive compounds, Cerebrolysin functions as a multifactorial neuromodulatory system, mimicking endogenous neurotrophic factors such as NGF, BDNF, GDNF, and CNTF in functional activity rather than direct molecular identity.

The lyophilized powder form offers enhanced stability, transport safety, batch consistency, and reconstitution flexibility, making it particularly suitable for long-term storage, preclinical research pipelines, and multi-center experimental designs. Upon reconstitution, Cerebrolysin solutions demonstrate excellent aqueous solubility and compatibility with standard laboratory buffers used in in vitro, ex vivo, and in vivo neuroscience studies.

Extensive experimental literature supports Cerebrolysin’s role in:

  • Promoting neuronal survival under ischemic or oxidative stress

  • Enhancing synaptic plasticity and dendritic remodeling

  • Modulating neuroinflammatory signaling pathways

  • Supporting neurogenesis and neuronal differentiation

Due to its multi-target and systems-level mechanism, Cerebrolysin is frequently selected for complex disease models where monotherapy with single-pathway agents proves insufficient, including Alzheimer’s disease, Parkinson’s disease, vascular dementia, traumatic brain injury, and ischemic stroke models.

This product is supplied strictly for research and laboratory use only, not for human or veterinary administration.

Lyophilized Powder Factory Certificate
Lyophilized Powder Factory Certificate

Product Specifications

ParameterSpecification
Product NameCerebrolysin Lyophilized Powder
CompositionLow-molecular-weight neuroactive peptides and free amino acids
Molecular Weight Range< 10 kDa (peptide fraction)
SourcePorcine brain protein hydrolysate
AppearanceWhite to off-white lyophilized powder
SolubilityFreely soluble in sterile water or physiological buffers
Purity≥ 98% (HPLC, peptide fraction consistency)
Endotoxin Level< 0.1 EU/mg
Residual SolventsMeets research-grade specifications
FormulationLyophilized (freeze-dried)
Storage−20°C to 2–8°C (desiccated, protected from light)
Stability≥ 24 months under recommended storage
ReconstitutionSterile water, saline, or buffer systems
ApplicationNeuroscience & neurodegeneration research
CustomizationAvailable (bulk scale, concentration, packaging)

Expanded Notes:
Lyophilization ensures minimized peptide degradation, improved shelf life, and reliable reproducibility across experimental batches, especially critical in longitudinal neurobiology studies.


Mechanism of Action

Neurotrophic Factor Mimicry

Cerebrolysin exerts neurotrophic-like effects by functionally simulating endogenous growth factors, activating intracellular signaling cascades such as PI3K/Akt, MAPK/ERK, and CREB pathways, thereby supporting neuronal survival and differentiation.

Anti-Apoptotic Regulation

Experimental data indicate downregulation of pro-apoptotic mediators (e.g., Bax, caspase-3) and preservation of mitochondrial integrity, particularly under ischemic or excitotoxic conditions.

Synaptic Plasticity Enhancement

Cerebrolysin promotes synaptogenesis, dendritic spine density, and long-term potentiation (LTP), supporting learning and memory models in both cellular and animal systems.

Neuroinflammatory Modulation

The compound attenuates microglial overactivation and reduces pro-inflammatory cytokine release (TNF-α, IL-1β), contributing to neuroprotective microenvironments.

For a broader mechanistic framework, researchers may refer to our
Peptide Signaling Pathways in Molecular Research resource, which
summarizes receptor-mediated interactions, transcriptional modulation,
and downstream signaling cascades relevant to in vitro studies.

Lyophilization-freeze-drying-production-process
Lyophilization-freeze-drying-production-process

Applications

Neurodegenerative Disease Models

Used extensively in Alzheimer’s, Parkinson’s, Huntington’s, and ALS experimental systems to evaluate neuroprotection, cognitive preservation, and synaptic maintenance.

Ischemic & Traumatic Injury Research

Applied in stroke and traumatic brain injury (TBI) models to investigate neuronal recovery, angiogenesis, and functional restitution.

Cognitive & Behavioral Neuroscience

Supports learning, memory, and behavioral plasticity studies through synaptic modulation mechanisms.

Neurodevelopmental Studies

Employed in neuronal differentiation, neurite outgrowth, and developmental neurobiology research.

Cerebrolysin peptide lyophilized powder in a vial
Cerebrolysin peptide lyophilized powder in a vial

Research Models

  • Primary neuronal cultures

  • SH-SY5Y and PC12 cell lines

  • Rodent ischemia/reperfusion models

  • Transgenic neurodegeneration models

  • Behavioral and cognitive testing paradigms


Experimental Design Considerations

  • Optimize dosage empirically due to multi-component nature

  • Maintain consistent reconstitution protocols across experiments

  • Avoid repeated freeze–thaw cycles

  • Include appropriate vehicle and negative controls


Laboratory Safety & Handling Guidelines

  • For research use only

  • Use appropriate PPE (gloves, lab coat, eye protection)

  • Prepare solutions under aseptic conditions

  • Dispose of biological materials per institutional biosafety protocols


Integration with Multi-Omic & Computational Studies

Cerebrolysin is compatible with transcriptomic, proteomic, metabolomic, and network-based modeling approaches. Its systems-level effects make it particularly suitable for AI-assisted pathway analysis and multi-target drug modeling.


Keywords

Cerebrolysin lyophilized powder, Cerebrolysin research compound, neurotrophic agent, neuroprotection research, synaptic plasticity compound, neuroscience laboratory reagent, neurodegenerative disease model compound, cognitive research material


Shipping Guarantee

Temperature-controlled packaging with batch tracking and COA documentation provided.


Trade Assurance

Verified supplier with GMP-aligned production and quality control processes.


Payment Support

Supports wire transfer, escrow, and international trade payment options.


Disclaimer

This product is intended FOR RESEARCH USE ONLY.
Not for human or veterinary use.
Not intended for diagnosis, treatment, or prevention of any disease.

Additional information

Weight1.5 kg
Dimensions62 × 53 × 62 cm

2 reviews for Cerebrolysin Lyophilized Powder | 98%High purity Factory manufactured

  1. helianbouesso

    The product was packed securely for transit.

  2. Jeff

    good logistics speed!

Add a review

Your email address will not be published. Required fields are marked *

1. What is Cerebrolysin lyophilized powder used for in research?

Cerebrolysin lyophilized powder is primarily used in neuroscience and neurodegeneration research to study neuroprotection, synaptic plasticity, neuronal survival, and functional recovery in complex CNS disease models.

2. Is Cerebrolysin considered a single peptide compound?

No. Cerebrolysin is a multi-component neurotrophic preparation, consisting of low-molecular-weight peptides and free amino acids rather than a single defined peptide.

3. Why is the lyophilized form preferred for laboratory research?

Lyophilization improves chemical stability, reduces degradation risk during transport, allows flexible reconstitution, and ensures reproducibility across long-term experimental studies.

4. What molecular weight range do the active components fall into?

The peptide fraction of Cerebrolysin predominantly falls below 10 kDa, enabling efficient interaction with neuronal signaling pathways.

5. Can Cerebrolysin be used in in vitro neuronal cultures?

Yes. It is widely applied in primary neuron cultures, neuroblastoma cell lines, and differentiation assays to assess neurite outgrowth and synaptic development.

6. Is Cerebrolysin suitable for in vivo animal models?

Yes. It is commonly used in rodent models of stroke, traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease for mechanistic studies.

7. Does Cerebrolysin act as a neurotrophic factor?

Functionally, yes. While not identical to endogenous neurotrophic factors, Cerebrolysin mimics their biological activity by activating survival and plasticity-related signaling pathways.

8. What signaling pathways are influenced by Cerebrolysin?

Studies indicate modulation of PI3K/Akt, MAPK/ERK, CREB, and mitochondrial anti-apoptotic pathways.

9. Can Cerebrolysin reduce neuronal apoptosis in experimental models?

Experimental data suggest Cerebrolysin reduces apoptotic signaling and supports mitochondrial integrity under stress conditions.

10. Is Cerebrolysin compatible with synaptic plasticity studies?

Yes. It is frequently used in learning, memory, LTP, and dendritic spine density research.

11. Does Cerebrolysin influence neuroinflammation?

Cerebrolysin has been shown to modulate microglial activation and reduce pro-inflammatory cytokine release in experimental settings.

12. Can Cerebrolysin be combined with other neuroactive compounds?

Yes. It is often used in combination studies with antioxidants, growth factors, or metabolic regulators to explore synergistic effects.

13. What solvents are recommended for reconstitution?

Sterile water, saline, or commonly used physiological buffers such as PBS are suitable for reconstitution.

14. How should reconstituted solutions be handled?

Reconstituted solutions should be used promptly or stored short-term under controlled conditions to avoid degradation.

15. Are repeated freeze–thaw cycles acceptable?

No. Repeated freeze–thaw cycles should be avoided to maintain peptide integrity and experimental consistency.


EMI Options